ONCAlert | 2017 NANETS Symposium

Intra-Tumor Heterogeneity in Primary and Metastatic HCC

David J. Pinato, MD, PhD
Published Online:10:44 AM, Tue July 11, 2017

David J. Pinato, MD, PhD, NIHR Academic Clinical Lecturer in Medical Oncology, resident, Royal Brompton Hospital and Imperial College London, discusses an analysis of intra-tumor heterogeneity in the regulation of immune-tolerogenic pathways in primary and metastatic hepatocellular carcinoma (HCC). 
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.